NCT06168994View on ClinicalTrials.gov

Role of Eplerenone in Reducing Recurrence of Atrial Fibrillation in Patient With Structural Heart Disease

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

September 29, 2026

Study Completion Date

May 20, 2027

Conditions
Paroxysmal Atrial Fibrillation
Interventions
DRUG

Eplerenone

Amiodarone vs eplerenone in AF

All Listed Sponsors
lead

Assiut University

OTHER